Oxymetazoline 0.05% nasal solution

DRUG3 trials

Conditions

Autonomic FailureCarious Exposure of PulpOrthostatic HypotensionPersistent Allergic RhinitisPrimary Molar PulpotomyPrimary Molar ToothPulp Disease, DentalPulp Inflammation

Phase 1

Treatment of Orthostatic Hypotension in Autonomic Failure

CompletedNCT00223691

Vanderbilt UniversityAutonomic Failure, Orthostatic Hypotension

Start: 2002-03-31End: 2017-01-31Updated: 2017-01-18

Phase 4

Oxymetazoline Bridge Therapy With Intranasal Corticosteroids in Pediatric Allergic Rhinitis

CompletedNCT07593898

Dr. Behcet Uz Children's HospitalPersistent Allergic Rhinitis

Start: 2025-01-02End: 2026-01-16Updated: 2026-05-18

Unknown Phase

Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars

Not yet recruitingNCT07675330

Cairo UniversityCarious Exposure of Pulp, Primary Molar Pulpotomy, Primary Molar Tooth +5

Start: 2026-08-01End: 2027-12-01Target: 50Updated: 2026-06-30

Related Papers

Clinical Correlates of Efficacy of Pyridostigmine in the Treatment of Orthostatic Hypotension

Hypertension2024-12-275 citations

Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension

Hypertension2021-06-2822 citations

Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension

Hypertension2016-06-0776 citations